Physicians Symposium
State of the Art: Treatments, Targets, and Diagnosis – Ruemu E. Birhiray, MD
Multiple Myeloma: Emerging therapies – Kenneth Anderson, MD
Multiple Myeloma: What I recommend and how you should treat – Kenneth Anderson, MD
Waldenström’s Macroglobulinemia: Emerging options and current treatment paradigms – Steven Treon, MD, MA, PhD
Not so Benign Hematology – Robert Brodsky, MD
Benign Hematology: Coagulopathies and Beyond – Craig Kessler, MD
Indolent Lymphomas and Hodgkin’s Lymphoma: My treatment and emerging strategies – Bruce Cheson, MD, FACP, FAAS, FASCO
Aggressive B and T Cell Lymphomas: Treatment Paradigms in 2018 – John Leonard, MD
T. HOWARD LEE KEYNOTE LECTURE:
CHRONIC LYMPHOCYTIC LEUKEMIA: Targets, treatments, and resistance – Thomas Kipps, MD, PhD
Challenging Cases Presentation – Michael C. Wiemann, MD – Co-Chair
Chronic Myeloid Leukemia – Richard Larson, MD
Beyond JAK 2: Mastocytosis, CMML, Eosinophilic and Neutrophilic leukemia; Treatments, Paradigms, and Diagnosis
Ayalew Tefferi, MD, PhD
Myeloproliferative Neoplasms: What about JAK? PV, ET, MF – John Mascarenhas, MD, MS
Acute Myeloid Leukemias: Targets and Curability, so close but a journey so far – Martin Tallman, MD
Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome: CARS, CARTS, Mechanics, and beyond – Elias Jabbour, MD
Hematopoietic Stem Cell Transplantation: How I treat and when I transplant in 2018 – Richard Childs, MD, RADM, USPHS
Nurses Symposium
Lymphoma – Bruce Cheson, MD, FACP, FAAS, FASCO
Benign Hematology and Coagulopathy – Craig Kessler, MD
Chronic Leukemias – Richard Larson, MD
Myeloma – Paul Richardson, MD
Myeloproliferative Neoplasms – Ayalew Tefferi, MD, PhD
Not so Benign Hematology: Complementopathies and Aplastic Anemia – Robert Brodsky, MD
Recognition and Management of Toxicities of Oral Therapeutics in Hematologic Malignancies – Michelle Wright Mast, FNP-BC